supported by Foundation of NationalNatural Science Foundation of China(81241074,81071946 and 81302040);Natural Science Foundation of Jiangsu Province(BK2012485);Jiangsu Province's Medical Elite Program(RC201148);a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions;the Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU;Clinical Research Program from Health Ministry of China(Key project 2010to 2012);Scientific Research Program for Public Interests from the Health Ministry of China(No.201202017)
This study sought to analyze the clinical features and prognosis of multiple myeloma with isolated extramedullary relapse and with the absence of systemic progression.The clinical features and outcome were retrospecti...
目的探讨新型信号转导与转录激活因子-3(signal transducer and activator of transcription 3,STAT3)抑制剂齐福斯尼(kifocitanib,KIF)对多发性骨髓瘤(multiple myeloma,MM)细胞系OPM2和U266凋亡及细胞周期的影响。方法采用台盼蓝染色...